FY27 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
Special Notice from Department of Health and Human Services.
Data as of Nov 16, 2026 · Sources: SAM.gov and Grants.gov · About this data
Notice details
- Sub-tier agency
- FOOD AND DRUG ADMINISTRATION
- Notice type
- Special Notice
- Solicitation number
- FDABAA-27-00123
- Product/service code
- AJ11
- Posted
- Oct 31, 2026
- Response deadline
- Jan 22, 2027
- Source
- SAM.gov
Description
Amendment 001 - 10/30/26 - Updated the proposal due date from 2/1/27 at 5:00 pm to 1/22/27 at 5:00 pm. Updated the Special Notice Archive date from 15 days after response date to 09/30/27. In accordance with FAR 6.102(d)(2) and 35.016, the US Food and Drug Administration (FDA) solicits for the acquisition of basic and applied research and development proposals to support regulatory science and innovation through this Broad Agency Announcement (BAA). Research and development activities acquired under this BAA are intended to advance scientific knowledge in specific research areas as well as sub areas of interest defined within the BAA that serve the FDA in accomplishing its mission to protect and promote the health of our nation. Proposals submitted under this announcement are not limited solely to the PSC code "AJ11" specified in this announcement. FDA funds extramural research through an agency-wide Broad Agency Announcement (BAA) for research and development to support regulatory science and innovation.
Summarized from the official notice.
Official notice
Requirements and amendments are controlled by the official notice.
DSE verdict
The DSE fit verdict for this notice is available to DSE GovCon subscribers. It is not published on this page.
See DSE GovCon plans →Similar open notices
- Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & ResponseClosing in 4 daysPosted Oct 27, 2026 · Due Nov 20, 2026
- Posted Nov 14, 2026 · Due Nov 30, 2026
- Pre-Clinical Models of Infectious DiseasesClosing in 21 daysPosted Oct 20, 2026 · Due Dec 7, 2026
- UNifying Imaging with QUantum Entanglement (UNIQUE) Innovative Solutions Opening (ISO)Closing in 30 daysPosted Sep 25, 2026 · Due Dec 16, 2026
- ARPA-H Emerging Health Innovators (EHI) InitiativeClosing in 86 daysPosted Oct 23, 2026 · Due Feb 10, 2027
Get free alerts
Email alerts for notices like this one are free on DSE GovCon Intelligence.
Set up free alerts →Frequently asked questions
When is the response deadline?
The published deadline is Jan 22, 2027. That is 67 days after the data date.
What NAICS code applies?
NAICS 541714, Research and Development in Biotechnology (except Nanobiotechnology).
Which agency issued this notice?
Department of Health and Human Services.
Where is the official notice?
The link under Official notice opens the source listing.